資料載入中.....
|
請使用永久網址來引用或連結此文件:
https://ir.cnu.edu.tw/handle/310902800/30961
|
標題: | Synthesis and Antitumor Properties of BQC-Glucuronide, a Camptothecin Prodrug for Selective Tumor Activation |
作者: | Prijovich, Zeljko M. Burnouf, Pierre-Alain Chou, Hua-Cheng Huang, Ping-Ting Chen, Kai-Chuan Cheng, Tian-Lu Leu, Yu-Lin Roffler, Steve R. |
貢獻者: | Acad Sinica, Inst Biomed Sci, Acad Rd Natl Yang Ming Univ, Taiwan Int Grad Program Mol Med Acad Sinica, Acad Rd Kaohsiung Med Univ, Fac Biomed Sci & Environm Biol Chia Nan Univ |
關鍵字: | camptothecin glucuronide prodrug cancer targeted therapy beta-glucuronidase albumin influence ADEPT metastasis |
日期: | 2016-04 |
上傳時間: | 2018-01-18 11:38:46 (UTC+8) |
出版者: | Amer Chemical Soc |
摘要: | Major limitations of camptothecin anticancer drugs (toxicity, nonselectivity, water insolubility, inactivation by human serum albumin) may be improved by creating glucuronide prodrugs that rely on beta-glucuronidase for their activation. We found that the camptothecin derivative 5,6dihydro-4H-benzo [de] quinoline-camptothecin (BQC) displays greater cytotoxicity against cancer cells than the clinically used Norma tissue camptothecin derivatives SN-38 and topotecan even in the presence of human serum albumin. We synthesized the prodrug BQC-glucuronide (BQC-G), which was 4000 times more water soluble and 20-40 times less cytotoxic than BQC. Importantly, even in the presence of human serum albumin, BQC-G was efficiently hydrolyzed by beta-glucuronidase and produced greater cytotoxicity (IC50 = 13 nM) than camptothecin, 9-aminocamptothecin, SN-38, or topotecan (IC50 > 3000, 1370, 48, and 28 nM, respectively). BQC-G treatment of mice bearing human colon cancer xenografts with naturally or artificially elevated beta-glucuronidase activity produced significant antitumor activity, showing that BQC-G is a potent prodrug suitable for selective intratumoral drug activation. |
關聯: | Molecular Pharmaceutics, v.13 n.4, pp.1242-1250 |
顯示於類別: | [藥學系(所)] 期刊論文
|
文件中的檔案:
檔案 |
描述 |
大小 | 格式 | 瀏覽次數 |
index.html | | 0Kb | HTML | 1481 | 檢視/開啟 |
|
在CNU IR中所有的資料項目都受到原著作權保護.
|